News and Innovation
What is changing in clinical research — AI and digital tools, gene therapy and biotech, new trial models, and treatment advances in specific conditions. Written to explain why a development matters, not just to report that it happened.
-
New Hope Through Cutting-Edge Treatments
Read more: New Hope Through Cutting-Edge TreatmentsPatient-facing overview of how precision medicine, gene therapy, biologics, and targeted drugs deliver more effective treatment with fewer side effects, and why…
-
Enhancing Patient Experience Through Virtual Support
Read more: Enhancing Patient Experience Through Virtual SupportIntroduces the platform’s self-determination-based trial matching model with survey data and ROI claims, then explains how virtual support tools like telehealth, portals,…
-
Personalized Technology Improves Patient Retention
Read more: Personalized Technology Improves Patient RetentionLinks the broader trend of personalized healthcare technology, from 3D-printed implants to AI chatbots and wearables, to practical strategies for improving communication…
-
Digital Solutions to Improve Trial Access for All
Read more: Digital Solutions to Improve Trial Access for AllCovers AI-driven recruitment, generative AI scaling lessons from McKinsey research, and digital tools like eConsent and telemedicine that widen trial access, especially…
-
Progress in Rare Disease Treatment Gives Patients Hope
Read more: Progress in Rare Disease Treatment Gives Patients HopeSurveys recent rare disease breakthroughs including gene therapy, RNA treatments, drug repurposing, precision medicine, and AI, framing clinical trials and advocacy collaboration…
-
Transforming Rare Diseases into Treated Conditions
Read more: Transforming Rare Diseases into Treated ConditionsAn optimistic overview of progress in rare disease treatment, from gene and cell therapies to precision medicine, and the access, inclusivity, and…
-
How Pharma Is Pushing to Solve Rare Disease Challenges
Read more: How Pharma Is Pushing to Solve Rare Disease ChallengesRewritten Aug 2026 for patients and families. Explains why rare disease research funding matters to you, how pharma investment produces gene, small-molecule…
-
How Social Media Transforms Clinical Trial Engagement
Read more: How Social Media Transforms Clinical Trial EngagementOverview of how social media improves trial recruitment through targeted ads, inclusive outreach, transparent communication, and participant stories, plus challenges like privacy…
-
Digital Tools Embolden Patients in Clinical Trials
Read more: Digital Tools Embolden Patients in Clinical TrialsDescribes how wearables, telehealth, dashboards, and AI recruitment make trials more accessible and empowering, while cautioning that poorly chosen technology can exclude…
-
Why Ehlers Danlos Syndrome Is Often Missed
Read more: Why Ehlers Danlos Syndrome Is Often MissedExplains why Ehlers-Danlos syndrome diagnosis is so often delayed, covering fragmented symptoms, provider knowledge gaps, misread pain and fatigue, the upcoming 2026…